Sood AK - Search Results

1

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Schilder RJ, Brady WE, Lankes HA, Fiorica JV, Shahin MS, Zhou XC, Mannel RS, Pathak HB, Hu W, Alpaugh RK, Sood AK, Godwin AK. Schilder RJ, et al. Among authors: sood ak. Gynecol Oncol. 2012 Oct;127(1):70-4. doi: 10.1016/j.ygyno.2012.06.009. Epub 2012 Jun 16. Gynecol Oncol. 2012. PMID: 22710075 Free PMC article. Clinical Trial.

2

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.

Shahin MS, Hughes JH, Sood AK, Buller RE. Shahin MS, et al. Among authors: sood ak. Cancer. 2000 Nov 1;89(9):2006-17. doi: 10.1002/1097-0142(20001101)89:9<2006::aid-cncr18>3.3.co;2-z. Cancer. 2000. PMID: 11064359

3

Recurrent carcinoma in situ of a neovagina.

Lowe MP, Ault KA, Sood AK. Lowe MP, et al. Among authors: sood ak. Gynecol Oncol. 2001 Mar;80(3):403-4. doi: 10.1006/gyno.2000.6078. Gynecol Oncol. 2001. PMID: 11263940

4

p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.

Buller RE, Shahin MS, Holmes RW, Hatterman M, Kirby PA, Sood AK. Buller RE, et al. Among authors: sood ak. Am J Obstet Gynecol. 2001 Apr;184(5):891-902; discussion 902-3. doi: 10.1067/mob.2001.113856. Am J Obstet Gynecol. 2001. PMID: 11303196

5

The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.

Buller RE, Lallas TA, Shahin MS, Sood AK, Hatterman-Zogg M, Anderson B, Sorosky JI, Kirby PA. Buller RE, et al. Among authors: sood ak. Clin Cancer Res. 2001 Apr;7(4):831-8. Clin Cancer Res. 2001. PMID: 11309330

6

Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy.

Sood AK, Shahin MS, Sorosky JI. Sood AK, et al. Gynecol Oncol. 2001 Dec;83(3):599-600. doi: 10.1006/gyno.2001.6439. Gynecol Oncol. 2001. PMID: 11733979

7

Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study.

Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J. Bloss JD, et al. Among authors: sood ak. J Clin Oncol. 2002 Apr 1;20(7):1832-7. doi: 10.1200/JCO.2002.07.045. J Clin Oncol. 2002. PMID: 11919241 Clinical Trial.

8

Anorectal dysfunction after surgical treatment for cervical cancer.

Sood AK, Nygaard I, Shahin MS, Sorosky JI, Lutgendorf SK, Rao SS. Sood AK, et al. J Am Coll Surg. 2002 Oct;195(4):513-9. doi: 10.1016/s1072-7515(02)01311-x. J Am Coll Surg. 2002. PMID: 12375757

9

Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.

Fracasso PM, Blessing JA, Morgan MA, Sood AK, Hoffman JS. Fracasso PM, et al. Among authors: sood ak. J Clin Oncol. 2003 Aug 1;21(15):2856-9. doi: 10.1200/JCO.2003.03.077. J Clin Oncol. 2003. PMID: 12885801 Clinical Trial.

10

Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial.

Sood AK, Lush R, Geisler JP, Shahin MS, Sanders L, Sullivan D, Buller RE, Sorosky JI. Sood AK, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6080-5. doi: 10.1158/1078-0432.CCR-04-0574. Clin Cancer Res. 2004. PMID: 15447993 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,162 results

Search Page

Filters